scholarly journals Race Disparities in the Use of Prevention, Screening, and Monitoring Services in Michigan Medicare Beneficiaries With Type 2 Diabetes and Combinations of Multiple Chronic Conditions

2020 ◽  
Vol 38 (4) ◽  
pp. 363-370
Author(s):  
John Michael Clements ◽  
Brady Thomas West ◽  
Batoul Harissa ◽  
Nolan Hayden ◽  
Mishaal Mustafa Khan ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Conditions ◽  
Multiple Chronic Conditions ◽  
Medicare Beneficiaries ◽  
Race Disparities

scholarly journals Type 2 Diabetes and Chronic Conditions Disparities in Medicare Beneficiaries in the State of Michigan

2020 ◽  
Vol 359 (4) ◽  
pp. 218-225
Author(s):  
John M. Clements ◽  
Mariana Rosca ◽  
Carla Cavallin ◽  
Shelby Falkenhagen ◽  
Thomas Ittoop ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Conditions ◽  
The State ◽  
Medicare Beneficiaries

Management of patients with type 2 diabetes and multiple chronic conditions: A Delphi consensus of the Spanish Society of Internal Medicine

2016 ◽  
Vol 27 ◽  
pp. 31-36 ◽  
Author(s):  
Javier Ena ◽  
Ricardo Gómez-Huelgas ◽  
Demetrio Sánchez-Fuentes ◽  
Miguel Camafort-Babkowsk ◽  
Francesc Formiga ◽  
...  
Keyword(s):  
Internal Medicine ◽  
Type 2 Diabetes ◽  
Chronic Conditions ◽  
Multiple Chronic Conditions ◽  
Delphi Consensus ◽  
Spanish Society

The Clinical and Economic Effects of Switching Medicare Beneficiaries with Type 2 Diabetes from Analog to Human Insulin

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 4-OR
Author(s):  
JING LUO ◽  
NAZLEEN F. KHAN ◽  
THOMAS MANETTI ◽  
JAMES J. ROSE ◽  
ANI KALOGHLIAN ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Human Insulin ◽  
Economic Effects ◽  
Medicare Beneficiaries

scholarly journals User Experience and Potential Health Effects of a Conversational Agent-Based Electronic Health Intervention: Protocol for an Observational Cohort Study

10.2196/16641 ◽  
2020 ◽  
Vol 9 (4) ◽  
pp. e16641
Author(s):  
Marian Z M Hurmuz ◽  
Stephanie M Jansen-Kosterink ◽  
Harm op den Akker ◽  
Hermie J Hermens
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Chronic Pain ◽  
User Experience ◽  
Chronic Conditions ◽  
Healthy Lifestyle ◽  
Observational Cohort Study ◽  
Potential Health ◽  
Observational Cohort

Background While the average human life expectancy has increased remarkably, the length of life with chronic conditions has also increased. To limit the occurrence of chronic conditions and comorbidities, it is important to adopt a healthy lifestyle. Within the European project “Council of Coaches,” a personalized coaching platform was developed that supports developing and maintaining a healthy lifestyle. Objective The primary aim of this study is to assess the user experience with and the use and potential health effects of a fully working Council of Coaches system implemented in a real-world setting among the target population, specifically older adults or adults with type 2 diabetes mellitus or chronic pain. Methods An observational cohort study with a pretest-posttest design will be conducted. The study population will be a dynamic cohort consisting of older adults, aged ≥55 years, as well as adults aged ≥18 years with type 2 diabetes mellitus or chronic pain. Each participant will interact in a fully automated manner with Council of Coaches for 5 to 9 weeks. The primary outcomes are user experience, use of the program, and potential effects (health-related factors). Secondary outcomes include demographics, applicability of the virtual coaches, and user interaction with the virtual coaches. Results Recruitment started in December 2019 and is conducted through mass mailing, snowball sampling, and advertisements in newspapers and social media. This study is expected to conclude in August 2020. Conclusions The results of this study will either confirm or reject the hypothesis that a group of virtual embodied conversational coaches can keep users engaged over several weeks of interaction and contribute to positive health outcomes. Trial Registration The Netherlands Trial Register: NL7911; https://www.trialregister.nl/trial/7911 International Registered Report Identifier (IRRID) PRR1-10.2196/16641

scholarly journals Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA

2021 ◽  
Author(s):  
HoJin Shin ◽  
Sebastian Schneeweiss ◽  
Robert J. Glynn ◽  
Elisabetta Patorno
Keyword(s):  
Type 2 Diabetes ◽  
Line Treatment ◽  
Medicare Beneficiaries ◽  
First Line ◽  
Adult Type ◽  
Antidiabetic Treatment ◽  
Glucagon Like Peptide 1 ◽  
Lowering Drug ◽  
First Line Treatment

<p>Objective: We evaluated recent utilization trends and predictors of first-line antidiabetic treatment in patients with type 2 diabetes.</p> <p>Research Design and Methods: Using two large U.S. health insurance databases (Clinformatics and Medicare), we identified adult type 2 diabetes patients who initiated antidiabetic treatment from 2013 through 2019. Quarterly trends in use of first-line antidiabetic treatment were plotted overall and stratified by cardiovascular disease (CVD). Multinomial logistic regressions were fit to estimate predictors of first-line antidiabetic treatment, using metformin, the recommended first-line treatment for type 2 diabetes, as the common referent.</p> <p>Results: Metformin was the most frequently initiated medication used by 80.6% of Medicare beneficiaries and 83.1% of commercially insured patients. Sulfonylureas were used by 8.7% (Medicare) and 4.7% (commercial). Both populations had low use of sodium-glucose cotransporter 2 inhibitors (SGLT-2i, 0.8% [Medicare] and 1.7% [commercial]) and glucagon-like peptide 1 receptor agonists (GLP-1RA, 1.0% [Medicare] and 3.5% [commercial]), with increasing trends over time (P < 0.01). Initiators of antidiabetic drugs with established cardiovascular benefits (SGLT-2i and GLP-1RA) were more likely to be younger, and had prevalent CVD or higher socioeconomic status compared with initiators of metformin. </p> <p>Conclusions: Among adult patients with type 2 diabetes, metformin was by far the most frequent first-line treatment. While the use of SGLT-2i and GLP-1RA was low from 2013 through 2019, it increased among patients with CVD.</p>

Factors Associated With a Higher Risk of Undiagnosed Prediabetes in a Community-Dwelling Medicare Population

2020 ◽  
Vol 35 (2) ◽  
pp. 85-92
Author(s):  
Cynthia S. Valle-Oseguera ◽  
Carly A. Ranson ◽  
Patricia Tam ◽  
Jacqueline Le ◽  
Brandon Le ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Risk Assessment ◽  
High Risk ◽  
Community Dwelling ◽  
Screening Tools ◽  
Medicare Beneficiaries ◽  
Medication Therapy ◽  
Medicare Population ◽  
Increased Risk

OBJECTIVE: To identify characteristics in an ambulatory Medicare population that are significantly more likely to be associated with a high risk of undiagnosed prediabetes.<br/> DESIGN: Cross-sectional study.<br/> SETTING: Fourteen health clinics targeting Medicare beneficiaries were held throughout northern and central California during the fall of 2017.<br/> PATIENTS, PARTICIPANTS: Noninstitutionalized Medicare beneficiaries receiving medication therapy management services without self-reported diabetes.<br/> INTERVENTIONS: Beneficiaries were screened for their risk of type 2 diabetes mellitus (T2DM) through the use of the American Diabetes Association (ADA) risk assessment (score of ≥ 5 indicates increased risk of developing type 2 diabetes) by pharmacy students. For this study, patients with a score of ≥ 5 were considered to be at high risk for undiagnosed prediabetes.<br/> MAIN OUTCOME MEASURE(S): Characteristics significantly more likely to be identified in patients at high risk for undiagnosed prediabetes.<br/> RESULTS: A total of 683 Medicare beneficiaries without self-reported diabetes completed the ADA risk assessment, with 457 (66.9%) receiving a score of 5 or more. In those, the presence of hyperlipidemia, hypertension, obesity, coronary heart disease, and use of aspirin were all characteristics researchers identified as significantly more likely to be found in this group. In contrast, those of Asian race or who took dietary supplements were significantly less likely to score 5 or higher in the questionnaire.<br/> CONCLUSION: Identification of older adults at higher risk for undiagnosed prediabetes through the use of appropriate screening tools allows for targeted preventive interventions, potentially lowering risk of developing T2DM for selected patients.

scholarly journals A cluster-based approach for integrating clinical management of Medicare beneficiaries with multiple chronic conditions

PLoS ONE ◽  
2019 ◽  
Vol 14 (6) ◽  
pp. e0217696 ◽  
Author(s):  
Brent M. Egan ◽  
Susan E. Sutherland ◽  
Peter L. Tilkemeier ◽  
Robert A. Davis ◽  
Valinda Rutledge ◽  
...  
Keyword(s):  
Clinical Management ◽  
Chronic Conditions ◽  
Multiple Chronic Conditions ◽  
Medicare Beneficiaries
Sign in / Sign up

Export Citation Format

Share Document